Onesource Specialty Pharma Limited has informed the Exchange regarding Board meeting held on January 23, 2026 for approving the unaudited financial results for the quarter ended December 31,2025
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Onesource Specialty Pharma Limited informed the stock exchange that its Board of Directors met on January 23, 2026 to approve the unaudited financial results for the quarter ended December 31, 2025 (Q3 FY26). This is a routine procedural disclosure required before the company releases its quarterly earnings. No financial figures, performance details, or board decisions beyond the approval of results are mentioned in this filing.
No direct impact on shareholders or stock price from this announcement alone, as it is merely a confirmation that the board met to approve results. Investors should wait for the actual Q3 FY26 numbers to assess the company's performance.